In This Issue

Accreditation Statistics

As of August 1, 2023

Cellular Therapy Entities

  • Accredited: 255
  • Applicants: 26

Cord Blood Banks

  • Accredited: 53
  • Applicants: 9

Congratulations to the following organizations for achieving initial accreditation:

Pennsylvania Hospital, Penn Medicine: Adult autologous hematopoietic progenitor cellular therapy, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation

Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital: Adult autologous hematopoietic progenitor cellular therapy, immune effector cellular therapy administration, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation

A complete list of accredited organizations can be found at www.factglobal.org.

Register for the 2023 AcCELLerate Forum: Join in Person or Virtually

Posted in :: 2023 Volume 4 :: Thursday, July 27th, 2023

ASTCT™, CIBMTR® and the National Marrow Donor Program®(NMDP)/Be The Match® are excited to announce that registration is now open for the 2023 AcCELLerate Forum!

Participate in person or virtually in impactful conversations regarding patient needs, therapies, and access to cell and gene therapy with advocates, industry representatives, researchers, and providers. Together we will identify needs and opportunities in the field for advocacy and sustainability.

Preliminary agenda topics include:

  • 80/20 Updates
  • Access and Care Disparities in Cellular Therapy
  • Cost-Mitigating Approaches in Cellular Therapy
  • Future Directions in Cellular Therapy
  • Histocompatibility Impact on Safety and Efficacy
  • Logistics for Cell Therapy Delivery in Different Settings
  • Point-of-Care Manufacturing and Production
  • Regulatory Process for Approving New Products

View the up-to-date agenda (subject to change)

Register for the forum

Follow #accellerate23 for updates